These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36057290)

  • 1. Disorder-specific impaired neurocognitive function in major depression and generalized anxiety disorder.
    Luo W; Luo L; Wang Q; Li Y; Zhang Y; Hu Y; Yu Y; Yu S; Lu F; Chen J; Liu L; Du N; Langley C; Sahakian BJ; He Z; Li T
    J Affect Disord; 2022 Dec; 318():123-129. PubMed ID: 36057290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorder-specific cognitive profiles in major depressive disorder and generalized anxiety disorder.
    Hendriks SM; Licht CM; Spijker J; Beekman AT; Hardeveld F; de Graaf R; Penninx BW
    BMC Psychiatry; 2014 Apr; 14():96. PubMed ID: 24690413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective and objective cognitive functioning in untreated late-life depression: An exploration centered on comorbid generalized anxiety disorder.
    Jiang F; Zhang J; Yi Y; Tan A; Qin X; Wang P; Zhong X; Xiao J; Li J; Zhou B
    Compr Psychiatry; 2024 Aug; 133():152490. PubMed ID: 38772325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attentional networks in co-occurring generalized anxiety disorder and major depression disorder: Towards a staging approach to the executive control deficits.
    Coussement C; De Longueville X; Heeren A
    Compr Psychiatry; 2022 Feb; 113():152294. PubMed ID: 34942482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of comorbid anxiety symptoms on cognitive deficits in patients with major depressive disorder.
    Liu J; Dong Q; Lu X; Sun J; Zhang L; Wang M; Liu B; Ju Y; Wan P; Guo H; Zhao F; Zhang X; Zhang Y; Li L
    J Affect Disord; 2020 Jan; 260():91-96. PubMed ID: 31493645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue in female patients with major depression: the effect of comorbid anxiety disorders.
    Ferentinos P; Kontaxakis VP; Havaki-Kontaxaki BJ; Dikeos D; Papadimitriou GN; Lykouras L
    Psychiatriki; 2011; 22(4):320-9. PubMed ID: 22271845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differences of event-related potential components in patients with comorbid depression and anxiety, depression, or anxiety alone.
    Zhou X; Lin Z; Yang W; Xiang M; Zhou B; Zou Z
    J Affect Disord; 2023 Nov; 340():516-522. PubMed ID: 37572703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder.
    Zhou Y; Cao Z; Yang M; Xi X; Guo Y; Fang M; Cheng L; Du Y
    Sci Rep; 2017 Jan; 7():40511. PubMed ID: 28098176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disorder- and cognitive demand-specific neurofunctional alterations during social emotional working memory in generalized anxiety disorder and major depressive disorder.
    Xu X; Xin F; Liu C; Chen Y; Yao S; Zhou X; Zhou F; Huang Y; Dai J; Wang J; Zou Z; Kendrick KM; Zhou B; Becker B
    J Affect Disord; 2022 Jul; 308():98-105. PubMed ID: 35427713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample.
    Zbozinek TD; Rose RD; Wolitzky-Taylor KB; Sherbourne C; Sullivan G; Stein MB; Roy-Byrne PP; Craske MG
    Depress Anxiety; 2012 Dec; 29(12):1065-71. PubMed ID: 23184657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.
    Yoo I; Woo JM; Lee SH; Fava M; Mischoulon D; Papakostas GI; Kim EJ; Chung S; Ha JH; Jeon HJ
    J Affect Disord; 2015 Oct; 185():24-30. PubMed ID: 26142691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk.
    Kemp AH; Quintana DS; Felmingham KL; Matthews S; Jelinek HF
    PLoS One; 2012; 7(2):e30777. PubMed ID: 22355326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition.
    Kanchanatawan B; Thika S; Anderson G; Galecki P; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):168-176. PubMed ID: 28666826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study.
    Almeida SS; Christensen MC; Simonsen K; Adair M
    J Psychopharmacol; 2023 Mar; 37(3):279-288. PubMed ID: 36377523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of automatical thoughts among generalized anxiety disorder, major depressive disorder and generalized social phobia patients.
    Gül AI; Simsek G; Karaaslan Ö; Inanir S
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2916-21. PubMed ID: 26241548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiential Avoidance Predicts Persistence of Major Depressive Disorder and Generalized Anxiety Disorder in Late Adolescence.
    Mellick WH; Mills JA; Kroska EB; Calarge CA; Sharp C; Dindo LN
    J Clin Psychiatry; 2019 Oct; 80(6):. PubMed ID: 31644841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K; Andersen HF; Reines EH
    Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxonicity and network structure of generalized anxiety disorder and major depressive disorder: An admixture analysis and complex network analysis.
    Curtiss J; Klemanski DH
    J Affect Disord; 2016 Jul; 199():99-105. PubMed ID: 27100054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample.
    Ohaeri JU; Awadalla AW
    Med Sci Monit; 2012 Mar; 18(3):CR160-73. PubMed ID: 22367127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.